Hi, what are you looking for?
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...
– The 3D printer company’s secondary offering is an opportunity to look at its remarkable stock market performance, and the people who benefit from...
– Phillip Frost: What Israel needs today is 10 companies like Teva; one is not enough. – Phillip Frost / Getty – / By...
– Eyal Waldman justified delisting from the TASE at an investors conference in London. – – /By Shmulik Shelach/ “The decision to delist from...
– Professor Marta Weinstock-Rosin has always been used to live on the wrong side on the fence: in Austria she was ‘too Jewish’, in...
– Press release / SHAREHOLDER ALERT: Concerning the proposed acquisition of PROLOR Biotech by OPKO Health in a transaction valued at approximately $480 million....